Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-06-29

Clinical Trial Update: Fibrinogen Early In Severe Trauma studY Junior [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update on fibrinogen in severe trauma patients is reported with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fibrinogen Early In Severe Trauma studY Junior

Snippet

Sponsor: Gold Coast Hospital and Health Service | Conditions: Trauma, Hemorrhage | Phase 2 | Status: UNKNOWN